Cargando…

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma

BACKGROUND AND AIM: We evaluated the efficacy of rechallenge transcatheter arterial chemoembolization (TACE) after lenvatinib (LEN) treatment in patients with previous TACE failure/refractoriness. METHODS: We enrolled 63 consecutive patients with a history of TACE failure/refractoriness prior to LEN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchida‐Kobayashi, Sawako, Kageyama, Ken, Takemura, Shigekazu, Matsumoto, Kazuhiro, Odagiri, Naoshi, Jogo, Atsushi, Kotani, Kohei, Kozuka, Ritsuzo, Motoyama, Hiroyuki, Kawamura, Etsushi, Hagihara, Atsushi, Yamamoto, Akira, Fujii, Hideki, Tanaka, Shogo, Enomoto, Masaru, Tamori, Akihiro, Miki, Yukio, Kubo, Shoji, Kawada, Norifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667401/ https://www.ncbi.nlm.nih.gov/pubmed/36406645 http://dx.doi.org/10.1002/jgh3.12819

Ejemplares similares

High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use
por: Tamori, Akihiro, et al.
Publicado: (2020)

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
por: Kotani, Kohei, et al.
Publicado: (2023)

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization
por: Odagiri, Naoshi, et al.
Publicado: (2020)

Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment
por: Kozuka, Ritsuzo, et al.
Publicado: (2022)

Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication
por: Motoyama, Hiroyuki, et al.
Publicado: (2018)

Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication
por: Motoyama, Hiroyuki, et al.
Publicado: (2018)

Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21
por: Kawamura, Etsushi, et al.
Publicado: (2022)

Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease
por: Matsumoto, Yoshinari, et al.
Publicado: (2023)

Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed
por: Yoshida, Kanako, et al.
Publicado: (2017)

Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein
por: Yamamoto, Akira, et al.
Publicado: (2021)

Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor Location
por: Asano, Kazuo, et al.
Publicado: (2023)

Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed
por: Nonomura, Ayami, et al.
Publicado: (2021)

Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma
por: Suoh, Maito, et al.
Publicado: (2020)

The Albumin-bilirubin Score Detects Changes in the Liver Function during Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study
por: Kageyama, Ken, et al.
Publicado: (2021)

Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient
por: Suoh, Maito, et al.
Publicado: (2021)

Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma
por: Hai, Hoang, et al.
Publicado: (2017)

Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis: A retrospective observational study
por: Kotani, Kohei, et al.
Publicado: (2018)

Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma
por: Dong, Minh Phuong, et al.
Publicado: (2020)

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis
por: Fujii, Hideki, et al.
Publicado: (2021)

Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report
por: Terashima, Yuto, et al.
Publicado: (2022)

Development of a novel anti-hepatitis B virus agent via Sp1
por: Hayakawa, Michiyo, et al.
Publicado: (2020)

Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
por: Hayakawa, Michiyo, et al.
Publicado: (2020)

Successful treatment of rectal varices with antegrade transvenous sclerotherapy via the splenorenal shunt from the transjugular approach
por: Pas, Maciej, et al.
Publicado: (2022)

Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C
por: Takemura, Kazuya, et al.
Publicado: (2020)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma
por: Mitsuyama, Yasuhito, et al.
Publicado: (2023)

Anti-fibrotic treatments for chronic liver diseases: The present and the future
por: Odagiri, Naoshi, et al.
Publicado: (2021)

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
por: Takinami, Masaki, et al.
Publicado: (2020)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Hepatitis B virus infection and alcohol consumption
por: Iida-Ueno, Ayako, et al.
Publicado: (2017)

Selective Balloon-occluded Retrograde Transvenous Obliteration for Gastric Varices
por: Jogo, Atsushi, et al.
Publicado: (2019)

Repeated rough coiling technique of portosystemic shunt: A novel treatment for hepatic encephalopathy
por: Nakano, Mariko, et al.
Publicado: (2023)

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
por: Yoshida, Kanako, et al.
Publicado: (2021)

Splenic Vein Diameter is a Risk Factor for the Portal Venous System Thrombosis After Partial Splenic Artery Embolization
por: Ogawa, Satoyuki, et al.
Publicado: (2021)

The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases
por: Fujii, Hideki, et al.
Publicado: (2021)

Impact of combining Lenvatinib with Transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Long, Jianwu, et al.
Publicado: (2023)

Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
por: Kuroda, Hidekatsu, et al.
Publicado: (2022)

A case of primary small cell carcinoma of the liver that was treated with chemotherapy
por: Morikawa, Hiroyasu, et al.
Publicado: (2008)

New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma
por: Kawamura, Etsushi, et al.
Publicado: (2023)

Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study
por: Sasaki, Yachiyo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rhn4riiin8vfkne53778umcd93